Hepamore Tablet
Images are for reference. Actual packaging may vary.
Metadoxine (500mg) + Silymarin (140mg) + L-Ornithine L-Aspartate (150mg) + Vitamin B6 (Pyridoxine) (3mg) + Folic Acid (1.5mg)
Strip of 10 tablets • Tablet
Haven’t found an alternative? A health advisor can help you understand what to do next.
We haven't found a cheaper matching alternative in our catalogue right now. Our health advisors can help you explore other options.
Active composition
+4 more active ingredients
Silymarin exhibits antioxidant properties, scavenging free radicals and enhancing glutathione levels in liver cells.
Folic Acid is involved in DNA synthesis and red blood cell formation, essential for proper cell division and growth.
Medical applications
Hepamore Tablet is a combination pharmaceutical formulation containing Metadoxine (500 mg), Silymarin (140 mg), L-Ornithine L-Aspartate (150 mg), Vitamin B6 (Pyridoxine) (3 mg), and Folic Acid (1.5 mg), designed to support liver function and promote hepatic detoxification. Metadoxine acts as a hepatoprotective agent by accelerating the metabolism and elimination of toxic substances, thereby reducing oxidative stress and inflammation in hepatic tissues.
Silymarin, a well-known antioxidant derived from milk thistle, contributes to hepatocyte regeneration and stabilizes cellular membranes, preventing toxin-induced damage. L-Ornithine L-Aspartate facilitates ammonia detoxification by enhancing the urea cycle, which is critical in managing hepatic encephalopathy and improving nitrogen balance. Vitamin B6 plays a vital role in amino acid metabolism and supports enzymatic functions essential for liver health, while Folic Acid aids in DNA synthesis and repair, further contributing to cellular regeneration.
Hepamore Tablet is indicated for patients with acute and chronic liver disorders, including alcoholic liver disease, non-alcoholic fatty liver disease, and drug-induced hepatotoxicity. It is recommended to be used under medical supervision, with dosage tailored according to the severity of liver impairment and patient response. Regular monitoring of liver function tests is advised during therapy to assess efficacy and safety.
Dosage information not available. Please consult your doctor or pharmacist.
Important precautions
Side-effect information is not available for this medicine. Please consult your doctor or pharmacist.
Information regarding the use of Hepamore Tablet during pregnancy is not available. Please consult your doctor.
High Risk
Information regarding the use of Hepamore Tablet during breastfeeding is not available. Please consult your doctor.
Medical Advice
There is limited information available on the use of Hepamore Tablet in patients with kidney disease. Please consult your doctor.
Exercise Caution
It is not known whether Hepamore Tablet alters the ability to drive. Do not drive if you experience any symptoms that affect your ability to concentrate and react.
Consult Doctor
Hepamore Tablet is probably safe to use in patients with liver disease. Limited data available suggests that dose adjustment of Hepamore Tablet may not be needed in these patients. Please consult your doctor.
Regular Checkup
0 reviews for Hepamore Tablet







